RECOMBINANT INTERLEUKIN-2 DIRECTLY AUGMENTS THE CYTOTOXICITY OF HUMAN-MONOCYTES

被引:332
作者
MALKOVSKY, M [1 ]
LOVELAND, B [1 ]
NORTH, M [1 ]
ASHERSON, GL [1 ]
GAO, L [1 ]
WARD, P [1 ]
FIERS, W [1 ]
机构
[1] STATE UNIV GHENT,MOLEC BIOL LAB,B-9000 GHENT,BELGIUM
关键词
D O I
10.1038/325262a0
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
引用
收藏
页码:262 / 265
页数:4
相关论文
共 32 条
  • [11] HALE G, 1983, BLOOD, V62, P873
  • [12] EXPRESSION OF INTERLEUKIN-2 RECEPTORS AND BINDING OF INTERLEUKIN-2 BY GAMMA INTERFERON INDUCED HUMAN-LEUKEMIC AND NORMAL MONOCYTIC CELLS
    HERRMANN, F
    CANNISTRA, SA
    LEVINE, H
    GRIFFIN, JD
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1985, 162 (03) : 1111 - 1116
  • [13] A HUMAN LYMPHOCYTE-ASSOCIATED ANTIGEN INVOLVED IN CELL-MEDIATED LYMPHOLYSIS
    HILDRETH, JEK
    GOTCH, FM
    HILDRETH, PDK
    MCMICHAEL, AJ
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1983, 13 (03) : 202 - 208
  • [14] KELLEY VE, 1984, J IMMUNOL, V132, P240
  • [15] LEVIN J, 1970, J LAB CLIN MED, V75, P903
  • [16] CHARACTERIZATION OF HUMAN INTERLEUKIN-2 DERIVED FROM ESCHERICHIA-COLI
    LIANG, SM
    ALLET, B
    ROSE, K
    HIRSCHI, M
    LIANG, CM
    THATCHER, DR
    [J]. BIOCHEMICAL JOURNAL, 1985, 229 (02) : 429 - 439
  • [17] IS IMMUNOLOGICAL-TOLERANCE (NON-RESPONSIVENESS) A CONSEQUENCE OF INTERLEUKIN-2 DEFICIT DURING THE RECOGNITION OF ANTIGEN
    MALKOVSKY, M
    MEDAWAR, PB
    [J]. IMMUNOLOGY TODAY, 1984, 5 (12): : 340 - 343
  • [18] ENHANCEMENT OF SPECIFIC ANTI-TUMOR IMMUNITY IN MICE FED A DIET ENRICHED IN VITAMIN-A ACETATE
    MALKOVSKY, M
    DORE, C
    HUNT, R
    PALMER, L
    CHANDLER, P
    MEDAWAR, PB
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1983, 80 (20): : 6322 - 6326
  • [19] NONSPECIFIC INHIBITOR RELEASED BY T-ACCEPTOR CELLS REDUCES THE PRODUCTION OF INTERLEUKIN-2
    MALKOVSKY, M
    ASHERSON, GL
    STOCKINGER, B
    WATKINS, MC
    [J]. NATURE, 1982, 300 (5893) : 652 - 655
  • [20] MALKOVSKY M, 1983, J IMMUNOL, V130, P785